Loading
PDBj
メニューPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

3U9H

Complex structure of human tankyrase 2 with nicotinamide

3U9H の概要
エントリーDOI10.2210/pdb3u9h/pdb
分子名称Tankyrase-2, ZINC ION, SULFATE ION, ... (7 entities in total)
機能のキーワードprotein-ligand complex, diphtheria toxin like fold, transferase, adp-ribosylation
由来する生物種Homo sapiens (human)
細胞内の位置Cytoplasm: Q9H2K2
タンパク質・核酸の鎖数2
化学式量合計55663.18
構造登録者
Narwal, M.,Lehtio, L. (登録日: 2011-10-19, 公開日: 2011-11-02, 最終更新日: 2023-09-13)
主引用文献Narwal, M.,Venkannagari, H.,Lehtio, L.
Structural basis of selective inhibition of human tankyrases.
J.Med.Chem., 55:1360-1367, 2012
Cited by
PubMed Abstract: Tankyrases are poly(ADP-ribose) polymerases that have many cellular functions. They play pharmaceutically important roles, at least in telomere homeostasis and Wnt signaling, by covalently ADP-ribosylating target proteins and consequently regulating their functions. These features make tankyrases potential targets for treatment of cancer. We report here crystal structures of human tankyrase 2 catalytic fragment in complex with a byproduct, nicotinamide, and with selective inhibitors of tankyrases (IWR-1) and PARPs 1 and 2 (olaparib). Binding of these inhibitors to tankyrase 2 induces specific conformational changes. The crystal structures explain the selectivity of the inhibitors, reveal the flexibility of a substrate binding loop, and explain existing structure-activity relationship data. The first crystal structure of a PARP enzyme in complex with a potent inhibitor, IWR-1, that does not bind to the widely utilized nicotinamide-binding site makes the structure valuable for development of PARP inhibitors in general.
PubMed: 22233320
DOI: 10.1021/jm201510p
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.75 Å)
構造検証レポート
Validation report summary of 3u9h
検証レポート(詳細版)ダウンロードをダウンロード

227111

件を2024-11-06に公開中

PDB statisticsPDBj update infoContact PDBjnumon